A new variant of monkeypox (mpox) is rapidly spreading to countries that previously had no reported cases, raising global concerns and increasing demand for vaccines.
The Anglo-Swedish pharmaceutical giant AstraZeneca reached a valuation of £200.3 billion (€233.14 billion) on Wednesday, making it the only UK-listed company to achieve this milestone. The company’s success is largely attributed to the continued strength of its cancer drug portfolio, which has propelled its market valuation significantly.
Sanofi has entered negotiations to sell a 50% stake in its consumer health division, Opella, to private equity firm Clayton, Dubilier & Rice (CD&R) for €15 billion. If finalized, this will be one of the largest deals of the year.
Novo Nordisk shares fell by 20% on Friday after the company’s latest weight loss drug, CagriSema, failed to meet expectations in clinical trials. This decline wiped out €90 billion in market value, marking the steepest single-day drop in the company’s history.
No account yet?
Create an AccountYou must be 18 years of age or older to view page. Please verify your age to enter.
Your access is restricted because of your age.
